BRÈVE

sur Symrise AG (isin : DE000SYM9999)

Change at the head of Symrise AG: Dr Jean-Yves Parisot appointed CEO

February 29, 2024 marks a turning point for Symrise AG with the appointment of Dr. Jean-Yves Parisot as the new CEO, succeeding Dr. Heinz-Jürgen Bertram after 15 years of distinguished service at the company's management. Dr Parisot, member of the Executive Committee and head of the Taste, Nutrition & Health segment, was chosen for his international experience and strategic vision. This transition, which will take effect on March 31, 2024, has been announced as smooth and carefully planned.

Dr Heinz-Jürgen Bertram steps down having made a significant contribution to Symrise's positioning as a global industry leader, securing the company a respected place within the DAX-40 index through an acquisition strategy targeted and sustained organic growth. The Supervisory Board expresses its deep gratitude to Dr. Bertram for his dedication and significant impact on the growth of Symrise.

Dr Parisot's appointment is enthusiastically welcomed, recognizing his key role in developing strategic segments of the business. His previous experience and active participation within the sector, including his presidency of the International Organization of the Flavor Industry (IOFI) since 2023, positions him as a leader capable of steering Symrise towards new horizons of success.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Symrise AG